Altor BioScience
Tracked across 18 events · 178 articles · First seen Apr 01, 2026 · Last active Aug 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Altor BioScience has licensed vaccine technology from the United States — Centers for Disease Control and Prevention>>> and is developing an injectable rotavirus vaccine, which could significantly expand its market presence and contribute to global health.
Jun 09, 2026 · 6 articles
Business
Impact: Altor BioScience is hosting a Capital Markets Day to showcase its commercial momentum for MagnetOs and its plans for scalable growth, aiming to increase enterprise value and support long-term success.
Jun 17, 2026 · 6 articles
Tech
Impact: Altor BioScience announced the initiation of the final stage of its PF614-MPAR-102 clinical study, which is a significant step in the development of its novel opioid overdose-protection technology. This could lead to a new standard for opioid safety and expand its market reach.
Jun 26, 2026 · 6 articles
Business
Impact: Altor BioScience announced the pricing of a public offering of 10,000,000 shares of its common stock at $15.00 per share, expecting to raise $150.0 million. This capital will fund clinical trials, preclinical studies, manufacturing, and other general corporate purposes, which is positive for its operations and growth.
Jun 03, 2026 · 12 articles
Regulatory
Impact: Altor BioScience secured KRW 300 billion in financing from the Canada — Canada Growth Fund, which will accelerate the development of its pneumococcal vaccine candidate GBP410 and enhance its manufacturing capabilities. This funding strengthens its position in the global vaccine market and contributes to Korea's vaccine sovereignty.
May 29, 2026 · 6 articles
Business
Impact: Altor BioScience>>> is transferring its vaccine technology and manufacturing know-how to Venezuelan Petroleum Company>>> as part of a strategic expansion into Latin America, securing preferential negotiation rights for future vaccine products.
May 25, 2026 · 9 articles
Tech
Impact: Altor BioScience is leading the ROTOR project, developing an AI-powered platform for vaccine development, which enhances its R&D capabilities and global standing in the biotechnology sector.
Jul 02, 2026 · 7 articles
Business
Impact: Altor BioScience is the acquirer, becoming a fully integrated seed company. This acquisition enhances its commercial capabilities and market position, likely boosting investor confidence and growth prospects.
Jul 28, 2026 · 6 articles
Business
Impact: Altor BioScience is the issuer of the offering, raising $300 million to fund R&D and expansion. The capital raise supports growth but dilutes existing shareholders.
Aug 04, 2026 · 6 articles
Tech
Altor BioScience submitted a Clinical Trial Application to the South Africa — South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive…
Impact: Altor BioScience is the sponsor of the Phase 1b trial, advancing its RSM01 candidate into pediatric development. This strengthens its pipeline and positions it in the RSV antibody market.
Jul 20, 2026 · 7 articles
Tech
Impact: Altor BioScience is collaborating with SciBase on the DETECT-AD study, which is the first study through their partnership, potentially benefiting its research and development efforts.
Jun 10, 2026 · 7 articles
Tech
Impact: Altor BioScience>>> sells NAD+ supplements, and its senior vice president, Andrew Shao>>>, downplayed the impact of the new study, emphasizing tissue-level NAD+ decline.
May 23, 2026 · 6 articles
Business
Impact: Altor BioScience is a contract research organisation involved in the preclinical studies, potentially gaining revenue from the project.
Jul 28, 2026 · 6 articles
Business
India — Gujarat Chief Minister Bhupendrabhai Patel led a week-long delegation visit to the United States and Canada from August 22-25, 2026, to promote investment opportunities ahead of the Vibrant India — Gujarat Global Summit…
Impact: Met with the delegation to discuss potential partnerships.
Aug 22, 2026 · 6 articles
Business
Impact: Altor BioScience is mentioned through its CEO, Vương Triều, who commented on the partnership between TechForce Robotics and Oncotelic Therapeutics.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Altor BioScience live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard